CNBC’s Jim Cramer delivers his daily Mad Dash.

July 7 (Reuters) - Obesity-focused clinical-stage biotechnology company Kalohexis on Tuesday confidentially filed to go public in the U.S., adding to an activity rebound in the initial public offering ...

"Complex chemical processes are essential for making DNA." This long-held assumption in the field of biotechnology has been ...

Explore the revolutionary potential of biotechnology and gene editing, alongside crucial ethical considerations and ...

Seeking biotech investment, breakthrough innovations, or a strategic gateway to the Asia-Pacific? The answers await in Hong Kong this September.HONG KONG, July 7, 2026 /PRNewswire/ -- The 5th Hong ...

As the head of NIST, Raman will be charged with overseeing high-profile work in areas like artificial intelligence, quantum science and biotechnology.

The couple grew up in the same village.

Like tectonic plates colliding, humanism and the humanities are confronting movements that question long-held definitions of ...

IBB, one of the largest exchange-traded funds focused on biotechnology, manages approximately $8.28 billion in assets and ...

Veteran biosensor innovator and technology leader brings decades of experience developing and scaling breakthrough ...

In South San Francisco, Genentech showed that recombinant DNA technology could transform medicine and create therapies once ...

In an interview, synthetic biologist Peter Carr explains research on synthetic cells, their potential benefits and hazards, ...